Cannasouth shares higher on research green light

Cannasouth shares higher on research green light
Brent Melville
Cannasouth shares were a bright spark on the market yesterday, jumping 6.9 percent to $1.08 on news the medicinal cannabis firm had received a licence for research and formulation activity. The licence, issued under the New Zealand Medicinal Cannabis scheme in force since April 1, applies specifically to the firm’s Hamilton site which had been operating under an older medical research licence.  The green light for research, which involved a site audit by the newly formed Medicinal Cannabis Agency, is one of 13 issued so far under the sche...

More Listed Companies

How ‘shareholder value’ became a Wall Street mantra
Policy

How ‘shareholder value’ became a Wall Street mantra

Michael Jensen inspired the transformation of capitalism. Was he a hero or a villain?

Bloomberg 13 Apr 2024
How many boards should a director sit on?
Listed Companies

Simon Robertson: How many boards should a director sit on?

An attempt to judge the composition trends in NZX boards is challenging.

Simon Robertson 13 Apr 2024
Wellington council picks Precinct for major civic square project
Property

Wellington council picks Precinct for major civic square project

Firm will fund and build the new five-star green building.

Staff reporters 11 Apr 2024
Numbers and letters for investors
Markets

Simon Robertson: Numbers and letters for investors

A plea for standardised financial reporting from NZX-listed companies.

Simon Robertson 02 Mar 2024